NCT03935633View on ClinicalTrials.gov

Short-term Clinical Study of CN128 in Thalassemia Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

May 6, 2019

Study Completion Date

December 17, 2019

Conditions
Thalassemia
Interventions
DRUG

CN128 Tablets

Iron chelator， oral tablets

Trial Locations (1)

310003

The first affiliated hospital, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Hangzhou Zede Pharma-Tech Co., Ltd.

OTHER

NCT03935633 - Short-term Clinical Study of CN128 in Thalassemia Patients | Biotech Hunter | Biotech Hunter